(FC) Franklin Covey - Ratings and Ratios
Training, Consulting, Leadership, Execution, Platforms
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 39.3% |
| Value at Risk 5%th | 56.2% |
| Relative Tail Risk | -12.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.45 |
| Alpha | -72.57 |
| CAGR/Max DD | -0.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.546 |
| Beta | 1.260 |
| Beta Downside | 1.627 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.14% |
| Mean DD | 28.72% |
| Median DD | 22.49% |
Description: FC Franklin Covey October 27, 2025
Franklin Covey Co. (NYSE: FC) delivers execution-focused training and consulting across sales performance, productivity, customer loyalty, leadership, and education improvement, serving both organizations and individuals worldwide through Direct Offices, International Licensees, and an Education Practice segment.
In addition to classic workshops, the firm monetizes digital platforms such as All Access Pass and Leader in Me, and licenses flagship content-including *The 7 Habits of Highly Effective People*, *The Speed of Trust*, *Multipliers*, *The 4 Disciplines of Execution*, and *Trust & Inspire*-as subscription-based learning solutions.
Recent financial snapshots (FY 2023) show revenue of roughly $1.2 billion, with subscription-based services contributing about 35 % of total sales and growing at an estimated 12 % year-over-year, while operating margin hovered near 10 % (subject to quarterly fluctuations and accounting adjustments). The company’s cash conversion cycle has improved to ~45 days, reflecting tighter working-capital management.
Key sector drivers include corporate training spend, which historically tracks with discretionary-budget health and tends to accelerate during periods of digital transformation; the broader research-and-consulting services market is projected to expand at a 5-6 % CAGR through 2028, powered by demand for measurable performance-improvement outcomes and remote-learning platforms.
For a data-rich, third-party perspective on FC’s valuation dynamics, you may find ValueRay’s analyst toolkit useful for deeper due-diligence.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (3.07m TTM) > 0 and > 6% of Revenue (6% = 16.0m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -11.28pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -10.41% (prev -0.77%; Δ -9.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 29.0m > Net Income 3.07m (YES >=105%, WARN >=100%) |
| Net Debt (-30.9m) to EBITDA (15.4m) ratio: -2.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (12.8m) change vs 12m ago -4.55% (target <= -2.0% for YES) |
| Gross Margin 76.22% (prev 76.27%; Δ -0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 105.9% (prev 109.8%; Δ -3.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.59 (EBITDA TTM 15.4m / Interest Expense TTM 564.0k) >= 6 (WARN >= 3) |
Altman Z'' 1.87
| (A) -0.11 = (Total Current Assets 129.5m - Total Current Liabilities 157.3m) / Total Assets 242.9m |
| (B) 0.52 = Retained Earnings (Balance) 126.3m / Total Assets 242.9m |
| (C) 0.03 = EBIT TTM 6.54m / Avg Total Assets 252.2m |
| (D) 0.72 = Book Value of Equity 126.6m / Total Liabilities 176.0m |
| Total Rating: 1.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.22
| 1. Piotroski 5.0pt |
| 2. FCF Yield 10.61% |
| 3. FCF Margin 6.76% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -2.01 |
| 6. ROIC - WACC (= -5.70)% |
| 7. RoE 4.30% |
| 8. Rev. Trend 24.42% |
| 9. EPS Trend -30.76% |
What is the price of FC shares?
Over the past week, the price has changed by +4.66%, over one month by +9.77%, over three months by -12.52% and over the past year by -54.65%.
Is FC a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.3 | 64.3% |
| Analysts Target Price | 27.3 | 64.3% |
| ValueRay Target Price | 13.5 | -18.6% |
FC Fundamental Data Overview December 10, 2025
P/E Trailing = 66.2917
P/E Forward = 23.8663
P/S = 0.7531
P/B = 2.8868
P/EG = 1.1944
Beta = 0.672
Revenue TTM = 267.1m USD
EBIT TTM = 6.54m USD
EBITDA TTM = 15.4m USD
Long Term Debt = 1.31m USD (from longTermDebtTotal, two quarters ago)
Short Term Debt = 823.0k USD (from shortTermDebt, last quarter)
Debt = 823.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -30.9m USD (from netDebt column, last quarter)
Enterprise Value = 170.3m USD (201.1m + Debt 823.0k - CCE 31.7m)
Interest Coverage Ratio = 11.59 (Ebit TTM 6.54m / Interest Expense TTM 564.0k)
FCF Yield = 10.61% (FCF TTM 18.1m / Enterprise Value 170.3m)
FCF Margin = 6.76% (FCF TTM 18.1m / Revenue TTM 267.1m)
Net Margin = 1.15% (Net Income TTM 3.07m / Revenue TTM 267.1m)
Gross Margin = 76.22% ((Revenue TTM 267.1m - Cost of Revenue TTM 63.5m) / Revenue TTM)
Gross Margin QoQ = 75.50% (prev 76.46%)
Tobins Q-Ratio = 0.70 (Enterprise Value 170.3m / Total Assets 242.9m)
Interest Expense / Debt = 11.54% (Interest Expense 95.0k / Debt 823.0k)
Taxrate = 45.04% (3.58m / 7.96m)
NOPAT = 3.59m (EBIT 6.54m * (1 - 45.04%))
Current Ratio = 0.82 (Total Current Assets 129.5m / Total Current Liabilities 157.3m)
Debt / Equity = 0.01 (Debt 823.0k / totalStockholderEquity, last quarter 66.9m)
Debt / EBITDA = -2.01 (Net Debt -30.9m / EBITDA 15.4m)
Debt / FCF = -1.71 (Net Debt -30.9m / FCF TTM 18.1m)
Total Stockholder Equity = 71.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.26% (Net Income 3.07m / Total Assets 242.9m)
RoE = 4.30% (Net Income TTM 3.07m / Total Stockholder Equity 71.4m)
RoCE = 8.99% (EBIT 6.54m / Capital Employed (Equity 71.4m + L.T.Debt 1.31m))
RoIC = 4.95% (NOPAT 3.59m / Invested Capital 72.6m)
WACC = 10.64% (E(201.1m)/V(202.0m) * Re(10.66%) + D(823.0k)/V(202.0m) * Rd(11.54%) * (1-Tc(0.45)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.20%
[DCF Debug] Terminal Value 67.10% ; FCFE base≈30.4m ; Y1≈27.2m ; Y5≈23.1m
Fair Price DCF = 22.99 (DCF Value 279.5m / Shares Outstanding 12.2m; 5y FCF grow -12.96% → 3.0% )
EPS Correlation: -30.76 | EPS CAGR: -15.91% | SUE: -1.15 | # QB: 0
Revenue Correlation: 24.42 | Revenue CAGR: 4.11% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.15 | Chg30d=+0.100 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-08-31): EPS=1.07 | Chg30d=-0.150 | Revisions Net=-2 | Growth EPS=+86.8% | Growth Revenue=+0.2%
EPS next Year (2027-08-31): EPS=1.29 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+20.0% | Growth Revenue=+4.0%
Additional Sources for FC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle